![[GUIDE BAR]](../gif/cdguide.gif)
CELLULAR FUNCTION OF CD6  
DISEASE RELEVANCE OF CD6 AND FUNCTION OF CD6 IN INTACT ANIMAL  
MOLECULAR STRUCTURE OF CD6  
| CELL TYPE | MW UNREDUCED | MW REDUCED | Comment |
|---|---|---|---|
| Peripheral Blood T-Cells | 105 kDa or 130 kDa |
POST-TRANSCRIPTIONAL MODIFICATION OF CD6  
POST-TRANSLATIONAL MODIFICATION OF CD6  
SUBSTRATES FOR CD6   - No information
ENZYMES WHICH MODIFY CD6   - No information
LIGANDS FOR CD6 AND MOLECULES ASSOCIATED WITH CD6  
| MOLECULE | COMMENT |
|---|---|
| Activated leukocyte cell adhesion molecule (ALCAM) | Divalent cation-independent ligand for CD6. ALCAM binds the membrane proximal SRCR domain (domain 3) |
| gp90 | Potential divalent cation-dependent ligand(s) for CD6, currently unidentified |
| gp40 | Potential divalent cation-dependent ligand(s) for CD6, currently unidentified |
| NAME(Workshop IDs) | SOURCE or REFERENCE | COMMENT |
|---|---|---|
| 161.8 (NL034) | Ramon Villela, Barcelona, Spain |
SELECTION OF OTHER CD6-SPECIFIC REFERENCE MAB  
| NAME(Workshop IDs) | SOURCE or REFERENCE | COMMENT |
|---|---|---|
| M-T605 | Pharmingen | |
| SPV.L.14 | Immunotech |
REVIEWS
1. Aruffo A, Bowen MA, Patel DD, Haynes BF, Starling GC, Gebe JA and Bajorath J. CD6-ligand interactions: a paradigm for SRCR domain function? Immunol. Today 1997 18:498 PubMed
PRIMARY CITATIONS
2. Aruffo A, Melnick MB, Linsley PS and Seed B. The lymphocyte glycoprotein CD6 contains a repeated domain structure characteristic of a new family of cell surface and secreted proteins. J. Exp. Med. 1991 174:949 PubMed
3. Bowen MA, Patel DD, Li X, Modrell B, Malacko AR, Wang WC, Marquardt H, Neubauer M, Pesando JM, Francke U and et al. Cloning, mapping, and characterization of activated leukocyte-cell adhesion molecule (ALCAM), a CD6 ligand. J. Exp. Med. 1995 181:2213 PubMed
4. Bowen MA, Whitney GS, Neubauer M, Starling GC, Palmer D, Zhang J, Nowak NJ, Shows TB and Aruffo A. Structure and chromosomal location of the human CD6 gene: detection of five human CD6 isoforms. J. Immunol. 1997 158:1149 PubMed
5. Gangemi RM, Swack JA, Gaviria DM and Romain PL. Anti-T12, an anti-CD6 monoclonal antibody, can activate human T lymphocytes. J. Immunol. 1989 143:2439 PubMed
6. Patel DD, Wee SF, Whichard LP, Bowen MA, Pesando JM, Aruffo A and Haynes BF. Identification and characterization of a 100-kD ligand for CD6 on human thymic epithelial cells. J. Exp. Med. 1995 181:1563 PubMed
7. Patel DD, Wee SF, Whichard LP, Bowen MA, Pesando JM, Aruffo A and Haynes BF. Identification and characterization of a 100-kD ligand for CD6 on human thymic epithelial cells. J. Exp. Med. 1995 181:1563 PubMed
8. Robinson WH, Neuman de Vegvar HE, Prohaska SS, Rhee JW and Parnes JR. Human CD6 possesses a large, alternatively spliced cytoplasmic domain. Eur. J. Immunol. 1995 25:2765 PubMed
9. Starling GC, Whitney GS, Siadak AW, Llewellyn MB, Bowen MA, Farr AG and Aruffo AA. Characterization of mouse CD6 with novel monoclonal antibodies which enhance the allogeneic mixed leukocyte reaction. Eur. J. Immunol. 1996 26:738 PubMed
10. Wee S, Wang WC, Farr AG, Nelson AJ, Patel DD, Haynes BF, Linsley PS and Aruffo A. Characterization of a CD6 ligand(s) expressed on human- and murine-derived cell lines and murine lymphoid tissues. Cell. Immunol. 1994 158:353 PubMed
11. Whitney GS, Starling GC, Bowen MA, Modrell B, Siadak AW and Aruffo A. The membrane-proximal scavenger receptor cysteine-rich domain of CD6 contains the activated leukocyte cell adhesion molecule binding site. J. Biol. Chem. 1995 270:18187 PubMed
Portions copyright by Garland Press and by the International Workshops on Human Leukocyte Differentiation Antigens; used with permission
Modified 10/14/99 mpr@mail.nih.gov